The biotechnology spin-off Biocross is developing a laboratory test for accurate identification of Alzheimer’s disease patients. Biocross researchers are working on developing a multiparameter system, as it seems clear that a single marker is unlikely to facilitate accurate diagnosis of the disease.
A diagnosis against forgetting
